EUVIMEDEUVIMED entdecken
Fallbericht

Treatment of Retinitis Pigmentosa with Intravitreal Injection of Etamsylate: Case Report

Pedro Cuevas, Javier Angulo, Luis Outeiriño

Journal of Clinical Medical Research · 10.05.2026 · 7 (2) · 1-3

DOI: 10.46889/jcmr.2026.7201 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Medical Research, online erschienen am 10.05.2026. Verfasst von Pedro Cuevas und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystoid Macular Edema (CME) is a common complication of Retinitis Pigmentosa (RP) which increases with time and its treatment remains a challenge. Aberrant inflammation plays an essential role in RP. Here we report that local application of etamsylate, a powerful anti-inflammatory medicament, led to clinical improvement in a patient presenting this condition.

Zitieren

APA

Cuevas, P., Angulo, J., & Outeiriño, L. (2026). Treatment of Retinitis Pigmentosa with Intravitreal Injection of Etamsylate: Case Report. Journal of Clinical Medical Research, 7(2), 1-3. https://doi.org/10.46889/jcmr.2026.7201

Vancouver

Cuevas P, Angulo J, Outeiriño L. Treatment of Retinitis Pigmentosa with Intravitreal Injection of Etamsylate: Case Report. Journal of Clinical Medical Research. 2026;7(2):1-3. doi:10.46889/jcmr.2026.7201

BibTeX
@article{Cuevas2026,
  author = {Cuevas, Pedro and Angulo, Javier and Outeiriño, Luis},
  title = {Treatment of Retinitis Pigmentosa with Intravitreal Injection of Etamsylate: Case Report},
  journal = {Journal of Clinical Medical Research},
  year = {2026},
  volume = {7},
  number = {2},
  pages = {1--3},
  doi = {10.46889/jcmr.2026.7201}
}
Kostenlos starten →